Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Bookmark
Print
This page was added to your EVP, Research & Early Dev. of Bristol-myers Squibb Company (30-Year Financial, Insider Trades) Rupert Vessey (insider trades) sold 57,591 shares of BMY on 11/19/2020 at an average price of $61.3 a share. The total sale was $3.5 million.
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. Bristol-Myers Squibb Company has a market cap of $139.92 billion; its shares were traded at around $61.92 with and P/S ratio of 3.47. The dividend yield of Bristol-Myers Squibb Company stocks is 2.91%. Bristol-Myers Squibb Company had annual average EBITDA growth of 1.80% over the past ten years. GuruFocus has detected 3 severe warning signs with Bristol-Myers Squibb Company. .
- Warning! GuruFocus has detected 7 Warning Signs with BMY. Click here to check it out.
- BMY 30-Year Financial Data
- The intrinsic value of BMY
- Peter Lynch Chart of BMY
Directors and Officers Recent Trades:
- EVP, Research & Early Dev. Rupert Vessey sold 57,591 shares of BMY stock on 11/19/2020 at the average price of $61.3. The price of the stock has increased by 1.01% since.
For the complete insider trading history of BMY, click here
.
Subscribe
via Email
Subscribe RSS
